Redeye retains its positive view of CombinedX following a soft Q3 report, hurt by high employee turnover, despite lowering its Base Case somewhat. However, our mid and long-term forecasts assume much higher margin levels than seen in the last two quarters, so a rebound is crucial to retain those forecasts.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.

© Modular Finance, source Nordic Press Releases